Telehealth Treatment for Opioid Use Disorder During Pregnancy

This peer reviewed journal article OUD treatment and pregnancy outcomes among pregnant patients receiving OUD care through a telehealth addiction treatment program in the US. The patients identified in the study received buprenorphine or buprenorphine and naloxone treatment. "The primary outcome was continuous OUD care through pregnancy vs discharge due to loss to follow-up or administrative or financial reasons. Secondary outcomes included continued telehealth treatment vs transfer of care to a prenatal clinician, retention in care through 6 weeks’ postpregnancy, treatment adherence through urine drug screen confirmation of buprenorphine, and obstetric outcome."